Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
US Army
Teva
Citi
Daiichi Sankyo
Mallinckrodt
Express Scripts
Dow

Generated: April 22, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AZILSARTAN KAMEDOXOMIL

« Back to Dashboard

Clinical Trials for AZILSARTAN KAMEDOXOMIL

Trial ID Title Status Sponsor Phase Summary
NCT00362115 Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension Completed Takeda Phase 2 The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension.
NCT00376181 Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus Terminated Takeda Phase 3 The purpose of this study is to evaluate the efficacy and safety of pioglitazone-azilsartan, once daily (QD), in subjects with type 2 diabetes mellitus with poor glycemic control.
NCT00591253 Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension Completed Takeda Phase 3 The purpose of this study is to evaluate the effectiveness and safety of azilsartan medoxomil compared to placebo, once daily (QD), in African-American participants with essential hypertension.
NCT00591266 Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension Completed Takeda Phase 3 The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with amlodipine in treating individuals with essential hypertension, compared to treatment with amlodipine alone.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for AZILSARTAN KAMEDOXOMIL

Condition Name

Condition Name for AZILSARTAN KAMEDOXOMIL
Intervention Trials
Hypertension 25
Essential Hypertension 9
Type 2 Diabetes Mellitus 2
Type 2 Diabetes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for AZILSARTAN KAMEDOXOMIL
Intervention Trials
Hypertension 34
Diabetes Mellitus 7
Diabetes Mellitus, Type 2 5
Angina Pectoris 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for AZILSARTAN KAMEDOXOMIL

Trials by Country

Trials by Country for AZILSARTAN KAMEDOXOMIL
Location Trials
United States 405
Japan 42
Mexico 28
China 18
Germany 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for AZILSARTAN KAMEDOXOMIL
Location Trials
Ohio 18
Florida 17
California 17
Texas 17
South Carolina 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for AZILSARTAN KAMEDOXOMIL

Clinical Trial Phase

Clinical Trial Phase for AZILSARTAN KAMEDOXOMIL
Clinical Trial Phase Trials
Phase 4 5
Phase 3 25
Phase 2/Phase 3 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for AZILSARTAN KAMEDOXOMIL
Clinical Trial Phase Trials
Completed 29
Recruiting 7
Terminated 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for AZILSARTAN KAMEDOXOMIL

Sponsor Name

Sponsor Name for AZILSARTAN KAMEDOXOMIL
Sponsor Trials
Takeda 37
Lee's Pharmaceutical Limited 2
Arbor Pharmaceuticals, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for AZILSARTAN KAMEDOXOMIL
Sponsor Trials
Industry 42
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
QuintilesIMS
McKinsey
Johnson and Johnson
Express Scripts
Cerilliant
Fuji
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.